Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 2,373 | 1,463 | 473 | 0 | 0 |
| Gross Profit | 2,373 | 1,463 | 473 | N/A | N/A |
| Operating Expenses | 9,192 | 7,709 | 7,280 | 7,622 | 7,937 |
| Operating Income | -6,819 | -6,246 | -6,807 | -7,622 | -7,937 |
| Other Income | -352 | -702 | 4 | -2,379 | -462 |
| Pre-tax Income | -7,171 | -6,948 | -6,803 | -10,001 | -8,399 |
| Net Income Continuous | -7,171 | -6,948 | -6,803 | -10,001 | -9,398 |
| Net Income Discontinuous | 118 | 157 | N/A | 12,898 | 1,224 |
| Net Income | $-7,053 | $-6,791 | $-6,803 | $2,897 | $-8,174 |
| EPS Basic Total Ops | -84.58 | -92.51 | -92.51 | 39.21 | 3.08 |
| EPS Basic Continuous Ops | -79.74 | -94.71 | -92.51 | -134.80 | -21.59 |
| EPS Basic Discontinuous Ops | -4.85 | 2.20 | N/A | 173.57 | 24.67 |
| EPS Diluted Total Ops | -84.58 | -92.51 | -92.51 | 39.21 | 3.08 |
| EPS Diluted Continuous Ops | -79.74 | -94.71 | -92.51 | -134.80 | -21.59 |
| EPS Diluted Discontinuous Ops | -4.85 | 2.20 | N/A | 173.57 | 24.67 |
| EBITDA(a) | $-6,477 | $-5,946 | $-6,498 | $-7,167 | $-7,404 |